Laura Pw Ranum

University Of Minnesota Twin Cities

$25,888,014

Attributed

$32,261,268

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.8M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$44,602,822 · 22

By mechanism

R01$18,365,462 · 7

P01$17,495,536 · 7

R37$4,538,953 · 1

RF1$4,082,671 · 2

R13$120,200 · 5

Top collaborators

Most similar at University Of Minnesota Twin Cities

Same institution · by research overlap

Linda K McLoon$8,499,341
Eric A Newman$11,920,303

Others in their field

Top investigators on “Mutation”

Richard A Gibbs · Baylor College Of Medicine$276,143,183
David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
Randall J Bateman · Washington University$154,391,630
Eric Martin McDade · Washington University$96,219,353
Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056

Research focus

MutationMolecularProteinsTissuesFunctional DisorderMyotonic DystrophyBrainAffectInsightTranslationsToxic EffectAutopsyTranscriptCellsGenesPhenotypeNeuronsPathologySiteGeneticProgramsGain Of FunctionIn VivoPathway Interactions

Grant awards (99)

Molecular effects of metformin, PKR and TBI on C9orf72 ALS/FTD$705,919

R01 · FY2025 · NS · contact PI

Novel repeat associated non-AUG (RAN) proteins in sALS sFTD and SBMA: shared pathological features and unifying therapeutic opportunities$693,663

R01 · FY2025 · NS · contact PI

Contribution of RAN proteins to HD, SCA3 other CAG.CTG expansion diseases$575,911

R01 · FY2025 · NS · contact PI

Contribution of RAN proteins to HD, SCA3 other CAG.CTG expansion diseases$48,051

R01 · FY2025 · NS · contact PI

10th International Unstable Microsatellites and Human Disease Meeting$10,200

R13 · FY2025 · NS · contact PI

Contribution of RAN proteins to HD, SCA3 other CAG.CTG expansion diseases$570,607

R01 · FY2024 · NS · contact PI

Contribution of RAN proteins to HD, SCA3 other CAG.CTG expansion diseases$74,290

R01 · FY2024 · NS · contact PI

Contribution of RAN proteins to HD, SCA3 other CAG.CTG expansion diseases$38,674

R01 · FY2024 · NS · contact PI

Contribution of RAN proteins to HD, SCA3 other CAG.CTG expansion diseases$600,094

R01 · FY2023 · NS · contact PI

Contribution of RAN proteins to HD, SCA3 other CAG.CTG expansion diseases$74,290

R01 · FY2023 · NS · contact PI

Contribution of RAN proteins to HD, SCA3 other CAG.CTG expansion diseases$72,556

R01 · FY2023 · NS · contact PI

Immunotherapies for RAN protein diseases$26,239

R01 · FY2023 · NS · contact PI

Molecular effects of metformin, PKR and TBI on C9orf72 ALS/FTD$2,152,606

RF1 · FY2022 · NS · contact PI

Novel repeat associated non-AUG (RAN) proteins in sALS, sFTD and SBMA: shared pathological features and unifying therapeutic opportunities$1,930,065

RF1 · FY2022 · NS · contact PI

Contribution of RAN proteins to HD, SCA3 other CAG.CTG expansion diseases$610,876

R01 · FY2022 · NS · contact PI

Immunotherapies for RAN protein diseases$72,556

R01 · FY2022 · NS · contact PI

Repeat Associated non-AUG translation in Myotonic Dystrophy Type 1$33,882

R01 · FY2022 · NS · contact PI

Molecular Genetic Characterization of SCA8$636,489

R37 · FY2021 · NS · contact PI

Contribution of RAN proteins to HD, SCA3 other CAG.CTG expansion diseases$610,876

R01 · FY2021 · NS · contact PI

Molecular Characterization of ALS/FTD in a novel C9orf72 BAC mouse model.$695,423

R01 · FY2020 · NS · contact PI

Molecular Genetic Characterization of SCA8$670,405

R37 · FY2020 · NS · contact PI

Molecular Genetic Characterization of SCA8$712,855

R37 · FY2019 · NS · contact PI

Molecular Characterization of ALS/FTD in a novel C9orf72 BAC mouse model.$705,907

R01 · FY2019 · NS · contact PI

Molecular Characterization of ALS/FTD in a novel C9orf72 BAC mouse model.$741,646

R01 · FY2018 · NS · contact PI

Molecular Genetic Characterization of SCA8$626,676

R37 · FY2018 · NS · contact PI

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects$1,163,268

P01 · FY2017 · NS · contact PI

Molecular Characterization of ALS/FTD in a novel C9orf72 BAC mouse model.$839,776

R01 · FY2017 · NS · contact PI

Molecular Genetic Characterization of SCA8$626,676

R37 · FY2017 · NS · contact PI

REPEAT-ASSOCIATED NON-ATG TRANSLATION IN DM1 AND DM2$468,792

P01 · FY2017 · NS · contact PI

ADMINISTRATIVE CORE$37,125

P01 · FY2017 · NS · contact PI

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects$1,180,108

P01 · FY2016 · NS · contact PI

Molecular Characterization of ALS/FTD in a novel C9orf72 BAC mouse model.$773,641

R01 · FY2016 · NS · contact PI

Molecular Genetic Characterization of SCA8$626,676

R37 · FY2016 · NS · contact PI

REPEAT-ASSOCIATED NON-ATG TRANSLATION IN DM1 AND DM2$389,619

P01 · FY2016 · NS · contact PI

Molecular Characterization of ALS/FTD in a novel C9orf72 BAC mouse model.$85,360

R01 · FY2016 · NS · contact PI

ADMINISTRATIVE CORE$37,125

P01 · FY2016 · NS · contact PI

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects$1,202,454

P01 · FY2015 · NS · contact PI

Molecular Genetic Characterization of SCA8$639,176

R37 · FY2015 · NS · contact PI

REPEAT-ASSOCIATED NON-ATG TRANSLATION IN DM1 AND DM2$398,849

P01 · FY2015 · NS · contact PI

ADMINISTRATIVE CORE$37,125

P01 · FY2015 · NS · contact PI

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects$1,206,162

P01 · FY2014 · NS · contact PI

REPEAT-ASSOCIATED NON-ATG TRANSLATION IN DM1 AND DM2$403,432

P01 · FY2014 · NS · contact PI

ADMINISTRATIVE CORE$36,753

P01 · FY2014 · NS · contact PI

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects$1,261,372

P01 · FY2013 · NS · contact PI

REPEAT-ASSOCIATED NON-ATG TRANSLATION IN DM1 AND DM2$415,641

P01 · FY2013 · NS · contact PI

ADMINISTRATIVE CORE$37,125

P01 · FY2013 · NS · contact PI

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects$1,198,350

P01 · FY2012 · NS · contact PI

Temporal/spatial RNA Expression Effects in DM1 and DM2$278,268

P01 · FY2012 · NS · contact PI

Administrative Core$278,264

P01 · FY2012 · NS · contact PI

7th International Conference on Unstable Microsatellites in Human Disease$10,000

R13 · FY2012 · NS · contact PI

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects$1,203,321

P01 · FY2011 · NS · contact PI

Role of Beta-III Spectrin in Spinocerebellar Ataxia Type 5$545,004

R01 · FY2011 · NS · contact PI

Temporal/spatial RNA Expression Effects in DM1 and DM2$424,815

P01 · FY2011 · NS · contact PI

Administrative Core$36,209

P01 · FY2011 · NS · contact PI

2011 CAG Triplet Repeat Disorders GRC/GRS$20,000

R13 · FY2011 · NS · contact PI

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects$741,413

P01 · FY2010 · NS · contact PI

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects$465,570

P01 · FY2010 · NS · contact PI

Temporal/spatial RNA Expression Effects in DM1 and DM2$431,096

P01 · FY2010 · NS · contact PI

Temporal/spatial RNA Expression Effects in DM1 and DM2$418,400

P01 · FY2010 · NS · contact PI

Molecular Genetic Characterization of SCA8$356,947

R01 · FY2010 · NS · contact PI

Role of Beta-III Spectrin in Spinocerebellar Ataxia Type 5$337,029

R01 · FY2010 · NS · contact PI

Role of Beta-III Spectrin in Spinocerebellar Ataxia Type 5$214,093

R01 · FY2010 · NS · contact PI

Molecular Genetic Characterization of SCA8$89,536

R01 · FY2010 · NS · contact PI

Administrative Core$37,284

P01 · FY2010 · NS · contact PI

Administrative Core$36,906

P01 · FY2010 · NS · contact PI

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects$1,212,531

P01 · FY2009 · NS · contact PI

Role of Beta-III Spectrin in Spinocerebellar Ataxia Type 5$550,697

R01 · FY2009 · NS · contact PI

Temporal/spatial RNA Expression Effects in DM1 and DM2$429,962

P01 · FY2009 · NS · contact PI

Molecular Genetic Characterization of SCA8$381,521

R01 · FY2009 · NS · contact PI

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects$95,508

P01 · FY2009 · NS · contact PI

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects$94,018

P01 · FY2009 · NS · contact PI

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects$45,541

P01 · FY2009 · NS · contact PI

Administrative Core$38,679

P01 · FY2009 · NS · contact PI

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects$1,271,938

P01 · FY2008 · NS · contact PI

Role of Beta-III Spectrin in Spinocerebellar Ataxia Type 5$567,475

R01 · FY2008 · NS · contact PI

Temporal/spatial RNA Expression Effects in DM1 and DM2$443,814

P01 · FY2008 · NS · contact PI

Molecular Genetic Characterization of SCA8$374,486

R01 · FY2008 · NS · contact PI

6th International Conference on Unstable Microsatellites and Human Disease$40,000

R13 · FY2008 · NS · contact PI

Administrative Core$38,699

P01 · FY2008 · NS · contact PI

Role of Beta-III Spectrin in Spinocerebellar Ataxia Type 5$604,393

R01 · FY2007 · NS · contact PI

Molecular Genetic Characterization of SCA8$438,387

R01 · FY2007 · NS · contact PI

DM2: Murine and cell Culture Models of CCUG RNA toxicity$431,903

R01 · FY2007 · NS · contact PI

Conference on Unstable Microsatellites & Human Disease$25,000

R13 · FY2007 · NS · contact PI

Molecular Genetic Characterization of SCA8$455,734

R01 · FY2006 · NS · contact PI

DM2: Murine and cell Culture Models of CCUG RNA toxicity$434,912

R01 · FY2006 · NS · contact PI

Conference on Unstable Microsatellites & Human Disease$15,000

R13 · FY2006 · NS · contact PI

DM2: Murine and cell Culture Models of CCUG RNA toxicity$435,550

R01 · FY2005 · NS

DM2: Murine and cell Culture Models of CCUG RNA toxicity$386,819

R01 · FY2004 · NS

MOLECULAR GENETIC CHARACTERIZATION OF SCA8$334,125

R01 · FY2004 · NS

CLONING/CHARACTERIZATING A MYOTONIC DYSTROPHY LOCUS$285,996

R01 · FY2004 · NS

MOLECULAR GENETIC CHARACTERIZATION OF SCA8$334,125

R01 · FY2003 · NS

CLONING/CHARACTERIZATING A MYOTONIC DYSTROPHY LOCUS$286,315

R01 · FY2003 · NS

MOLECULAR GENETIC CHARACTERIZATION OF SCA8$334,125

R01 · FY2002 · NS

CLONING/CHARACTERIZATING A MYOTONIC DYSTROPHY LOCUS$286,627

R01 · FY2002 · NS

CLONING/CHARACTERIZATING A MYOTONIC DYSTROPHY LOCUS$25,000

R01 · FY2002 · NS

MOLECULAR GENETIC CHARACTERIZATION OF SCA8$326,700

R01 · FY2001 · NS

CLONING/CHARACTERIZATING A MYOTONIC DYSTROPHY LOCUS$286,929

R01 · FY2001 · NS

MOLECULAR GENETIC CHARACTERIZATION OF SCA8$329,185

R01 · FY2000 · NS

CLONING/CHARACTERIZATING A MYOTONIC DYSTROPHY LOCUS$281,612

R01 · FY2000 · NS